Exploring blood markers related to delirium after heart surgery
Official title: Exploring of Serum Biomarkers of Delirium After Cardiovascular Surgery
Run by Huazhong University of Science and Technology · NCT06007755 · Data updated 2026-11-12
This study is trying to see if certain blood markers can help predict or explain delirium in patients after heart surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 113 (estimated) |
| Sponsor | Huazhong University of Science and Technology Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT06007755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients scheduled to undergo cardiovascular surgery who can provide informed consent.
✕Probably not a fit
Patients with a history of neurological or psychiatric diseases, or severe sensory impairments, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the relationship between serum biomarkers and the occurrence of delirium in patients following cardiovascular surgery. It focuses on the role of histone lactylation and Alzheimer's disease-related markers in understanding the mechanisms behind postoperative delirium. By analyzing serum samples, the study aims to identify potential biomarkers that could predict or explain delirium in this patient population. The findings could enhance our understanding of delirium and its inflammatory connections in the context of cardiovascular procedures.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of delirium in patients after cardiovascular surgery.
How similar studies have gone: While the specific approach of this study is novel, previous research has indicated a connection between biomarkers and delirium, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: patients who receive cardiovascular surgery * Patients participated voluntarily and signed informed consent Exclusion Criteria: * past medical history of neurological and psychiatric diseases; severe visual or hearing impairment;
Where it's running
-
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: Hua Zheng, Dr.
- Email: hzheng@hust.edu.cn
- Phone: 0086-27-83663173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can citicoline help prevent cognitive decline after delirium in older adults with hip fracture?
This study tests whether taking citicoline for 6 months after discharge helps prevent cognitive decline in adults 65 and older who had delirium during hospitalization for hip fracture.
-
Delirium and Light: Exploring Modifiable Risk Factors in Critically Ill Adults
This pilot observational study tests whether circadian-light factors influence delirium risk in adults recovering in critical care.
-
VR-based cognitive games to help prevent delirium after big surgery
A VR-based cognitive stimulation game is being tested to see if it can help prevent delirium in adults 65 and older after major surgery.
-
Computer-assisted cognitive stimulation for delirium in older adults
This will try adding tablet-based cognitive exercises to sleep and mobility support to see if they reduce delirium in people aged 60 and older in subacute care.
-
Letting patients drink clear fluids until called to the operating room to shorten pre-surgery fasting
This project will try letting elective procedure patients drink clear liquids until they're called to the operating room to see if fasting times, comfort, and perioperative outcomes improve.
-
Lemborexant to help Sleep and Delirium in older ICU patients
This study tests whether lemborexant, a sleep medication, helps improve sleep and reduce delirium in adults 65 and older in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.